drugset / Trial / NCT05742256

Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer

NCT05742256

Phase 1 Unknown 159 enrolled Qianfoshan Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, the effect of oxycodone combined with ultrasound-guided paravertebral nerve block on the postoperative analgesic effect of thoracoscopic lung cancer was investigated, and the effect and reasonable dose of oxycodone were explored, which provided a reference for the clinical multimodal analgesia after thoracoscopic lung cancer surgery.

Timeline

Start
2023-03-01
Primary completion
2024-07-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 1 mg/kg Intravenous
Subject Oxycodone Other / unclassified 1.5 mg/kg Intravenous
Comparator Sufentanil Other / unclassified 2 ug/kg Intravenous
Background Flurbiprofen Small molecule 50 mg
Background Ondansetron Other / unclassified 16 mg

Indications

No indication recorded.